drugset / Trial / NCT01988558

A Phase I/II to Assess Safety, Tolerability and Efficacy of DL-lactic Acid Syrup in Children With Recurrent Tonsillitis

NCT01988558 ↗

Phase 1/2 Completed 51 enrolled Yali Pharmaceuticals
RandomizedParallel-groupTriple-blindTreatment

Summary

The study objectives are to evaluate Tonsitin™ (10% Lactic Acid) safety, tolerability and preliminary efficacy, as a potent treatment for Recurrent Tonsillitis in children.

Timeline

Start
2013-12
Primary completion
2016-08
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Subject DL - Lactic Acid Unknown 10 % —

Indications